Junying Yuan
Junying Yuan is a prominent neuroscientist and biologist known for her pioneering work in the field of cell death mechanisms, particularly apoptosis and necroptosis. She has made significant contributions to understanding the molecular pathways that regulate cell death and their implications in various diseases.
Early Life and Education[edit | edit source]
Junying Yuan was born in China. She completed her undergraduate studies in biology at Fudan University in Shanghai. Yuan then moved to the United States to pursue her Ph.D. in neuroscience at Harvard University, where she worked under the mentorship of H. Robert Horvitz, a Nobel laureate known for his work on programmed cell death in Caenorhabditis elegans.
Research and Career[edit | edit source]
After completing her Ph.D., Yuan continued her research at Harvard Medical School, where she focused on the molecular mechanisms of apoptosis. Her groundbreaking discovery of the caspase family of proteases was a significant milestone in the field of cell death research. Caspases are crucial mediators of apoptosis, and their dysregulation is implicated in various diseases, including cancer and neurodegenerative disorders.
Yuan's research extended to the study of necroptosis, a form of programmed necrosis that is distinct from apoptosis. She identified key components of the necroptosis pathway, including RIPK1 and RIPK3 kinases, and demonstrated their roles in inflammation and immune response.
Awards and Honors[edit | edit source]
Junying Yuan has received numerous awards and honors for her contributions to science. She is a member of the National Academy of Sciences and the American Academy of Arts and Sciences. Her work has been recognized with prestigious awards such as the Lovelace Award and the Sloan Prize.
Current Work[edit | edit source]
Yuan currently holds a professorship at Harvard Medical School, where she continues to lead research on cell death mechanisms. Her lab focuses on the development of therapeutic strategies targeting apoptosis and necroptosis pathways for the treatment of diseases such as Alzheimer's disease, Parkinson's disease, and stroke.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD